TY - JOUR
T1 - Solitary pulmonary nodules caused by Mycobacterium avium complex
AU - OKAYAMA Respiratory Disease Study Group (ORDSG)
AU - Marukawa, Masaomi
AU - Taniguchi, Akihiko
AU - Kimura, Goro
AU - Kunichika, Naomi
AU - Kuyama, Shoichi
AU - Maeda, Yoshinobu
AU - Kiura, Katsuyuki
AU - Miyahara, Nobuaki
N1 - Publisher Copyright:
© 2019 The Japanese Respiratory Society
PY - 2019/11
Y1 - 2019/11
N2 - Background: The prevalence of Mycobacterium avium complex (MAC) pulmonary disease (PD) is increasing significantly in Japan. Among the patterns of MAC-PD, a solitary pulmonary nodule (SPN) is less common and often resembles lung cancer. The aim of this study was to identify the clinical features of MAC-SPN. Methods: SPNs culture-positive for MAC (definite cases) and culture-negative SPNs showing nucleic acid amplification test (NAAT)-positive status (probable cases) that presented between January 2007 and December 2017 were enrolled. The patients' clinical, laboratory, radiological, and microbiological findings and outcomes were investigated. Results: This study included 28 patients (median age, 66 years; 16 men, 12 women). All patients were asymptomatic when the disease was detected. Median SPN size was 23.5 mm. Twenty-six patients underwent video-assisted thoracoscopic surgery, while the others underwent percutaneous needle biopsy for diagnosis. Granulomatous inflammation was confirmed in all cases. Microbiologically, the 28 cases were divided into 17 in the definite group and 11 in the probable group. In both groups, M. avium was predominant. There were no significant differences in clinical and radiological findings and follow-up periods between the 2 groups. After diagnosis, 6 patients received medical treatment, while the others did not. The median follow-up period was 42 months, and no recurrence was observed in both groups. Conclusions: MAC should be considered in the differential diagnosis of SPNs in asymptomatic patients. To overcome the difficulties in diagnosing MAC-SPN, this study underscores the importance of diagnostic interventions and identification of MAC by culture and/or NAAT in biopsied specimens.
AB - Background: The prevalence of Mycobacterium avium complex (MAC) pulmonary disease (PD) is increasing significantly in Japan. Among the patterns of MAC-PD, a solitary pulmonary nodule (SPN) is less common and often resembles lung cancer. The aim of this study was to identify the clinical features of MAC-SPN. Methods: SPNs culture-positive for MAC (definite cases) and culture-negative SPNs showing nucleic acid amplification test (NAAT)-positive status (probable cases) that presented between January 2007 and December 2017 were enrolled. The patients' clinical, laboratory, radiological, and microbiological findings and outcomes were investigated. Results: This study included 28 patients (median age, 66 years; 16 men, 12 women). All patients were asymptomatic when the disease was detected. Median SPN size was 23.5 mm. Twenty-six patients underwent video-assisted thoracoscopic surgery, while the others underwent percutaneous needle biopsy for diagnosis. Granulomatous inflammation was confirmed in all cases. Microbiologically, the 28 cases were divided into 17 in the definite group and 11 in the probable group. In both groups, M. avium was predominant. There were no significant differences in clinical and radiological findings and follow-up periods between the 2 groups. After diagnosis, 6 patients received medical treatment, while the others did not. The median follow-up period was 42 months, and no recurrence was observed in both groups. Conclusions: MAC should be considered in the differential diagnosis of SPNs in asymptomatic patients. To overcome the difficulties in diagnosing MAC-SPN, this study underscores the importance of diagnostic interventions and identification of MAC by culture and/or NAAT in biopsied specimens.
KW - Diagnosis
KW - Mycobacterium avium complex
KW - Nontuberculous mycobacteriosis
KW - Nucleic acid amplification test
KW - Solitary pulmonary nodule
UR - http://www.scopus.com/inward/record.url?scp=85070187259&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85070187259&partnerID=8YFLogxK
U2 - 10.1016/j.resinv.2019.07.001
DO - 10.1016/j.resinv.2019.07.001
M3 - Article
C2 - 31402330
AN - SCOPUS:85070187259
SN - 2212-5345
VL - 57
SP - 566
EP - 573
JO - Respiratory Investigation
JF - Respiratory Investigation
IS - 6
ER -